We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

World's First SARS-CoV-2 Saliva PCR System for POC Delivers Results in 30 Minutes

By LabMedica International staff writers
Posted on 18 Aug 2022
Print article
Image: Sal6830 detects SARS-CoV-2 at the point of care in under 30 minutes (Photo courtesy of MicroGEM)
Image: Sal6830 detects SARS-CoV-2 at the point of care in under 30 minutes (Photo courtesy of MicroGEM)

The world continues to see COVID-19 cases and related deaths, with new cases and hospitalizations driven by the Omicron BA.5 variant. In today's 'new normal', where activities are resuming among vaccinated and unvaccinated people, testing can help relieve the burden and anxiety about who is sick and infectious. Now, the first-of-their-kind PCR-based system and saliva test can enable fast, simple, on-the-spot detection of COVID-19 infection.

The MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test from MicroGEM International (Charlottesville, VA, USA) give people timely answers about their health status, allowing them to quickly return to regular activities or immediately isolate and get care. The Sal6830 leverages MicroGEM's proprietary point of care technology, which combines enriched intact virus, thermophilic enzymatic RNA extraction, and microscale high-speed RT-PCR to capture whole virus to detect SARS-CoV-2 in under 30 minutes.

Sal6830's non-invasive saliva sampling, simple on-screen instructions, fast on-the-spot results, and portability provide an invaluable tool to quickly and accurately detect COVID-19 in settings ranging from healthcare centers, film production sets, and government and academic facilities, to mobile testing sites, retirement homes and long-term care communities. The Sal6830 SARS-CoV-2 Saliva Testing Kit's innovative cartridge design allows new targets to be added or replaced quickly, significantly reducing both assay and product development time.

The MicroGEM Sal6830 Point of Care PCR System and the MicroGEM Sal6830 SARS-CoV-2 Saliva Test recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The company plans on seeking authorization to expand the test menu and ruggedize the system to address austere field conditions presented in military and disaster medicine use cases, and adapt the system for the precision medicine healthcare market with quantitative gene expression panels used as biomarkers.

"Sal6830 is transforming the 'new normal' of living and working with COVID-19 by providing an easy, convenient saliva test that eliminates the discomfort of nasal swabs," said Geoff Stein, Director of Channel Partner Sales for MicroGEM.

Related Links:
MicroGEM International 

Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Automated Nucleic Acid Extractor
eLab
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more